Medicare Announces that it will Now Pay for Obesity Counseling
WASHINGTON, District of Columbia (MedPageToday.com and ABC News)—The Centers for Medicare and Medicaid Services (CMS) Medicare announced that it will pick up the tab for obesity screening and intensive behavioral counseling.
CMS, which first floated the obesity coverage plan last September, said it expects more than 30 percent of the Medicare population to qualify for the new benefit.
Beneficiaries with body mass index (BMI) values of 30kg/m2 or more can receive weekly in-person intensive behavioral therapy visits for one month, followed by visits every two weeks for an additional five months, fully paid by Medicare with no copayment.
Additional monthly sessions will be covered for up to six months afterward if the beneficiary has lost at least 6.6 pounds (3kg) during the first six months. The sessions should also include dietary counseling, the agency said.
Medicare patients who fail to lose the 6.6 pounds in six months may be re-evaluated at the one-year mark after the initial screening. Those showing “readiness to change” and a BMI value still at 30kg/m2 or more may receive another round of counseling paid by Medicare.
“It’s important for Medicare patients to enjoy access to appropriate screening and preventive services,” said outgoing CMS administrator Donald Berwick, MD, in a statement.
Counseling must take place in a primary care setting such as a physician’s office. It will not be covered when provided in skilled nursing facilities, hospitals, emergency departments, outpatient surgery centers, or hospices.
A primary care setting is defined as a setting in which there is provision of integrated, accessible healthcare services by clinicians who are accountable for addressing a large majority of personal healthcare needs, developing a sustained partnership with patients, and practicing in the context of family and community.
To qualify under the new benefit, counseling must be consistent with the “five As” listed in a United States Preventive Services Task Force recommendation, according to CMS’s decision memo:
• Assess: Ask about/assess behavioral health risk(s) and factors affecting choice of behavior change goals/methods.
• Advise: Give clear, specific, and personalized behavior change advice, including information about personal health harms and benefits.
• Agree: Collaboratively select appropriate treatment goals and methods based on the patient’s interest in and willingness to change the behavior.
• Assist: Using behavior change techniques (self-help and/or counseling), aid the patient in achieving agreed-upon goals by acquiring the skills, confidence, and social/environmental supports for behavior change, supplemented with adjunctive medical treatments when appropriate.
• Arrange: Schedule follow-up contacts (in person or by telephone) to provide ongoing assistance/support and to adjust the treatment plan as needed, including referral to more intensive or specialized treatment.
The agency had published the proposal to cover obesity screening and counseling under Medicare in early September, with a 90-day comment period to follow.
It based the decision on a review of studies and other evidence indicating that such counseling is effective in helping patients with obesity to lose significant weight, which in turn reduces risk of cardiovascular events and other adverse outcomes.
To read the full release, please visit http://www.medpagetoday.com/PublicHealthPolicy/Medicare/29940.
Obesity Action Coalition (OAC) Statement on the Impact of Obesity as a Factor in Child Neglect
TAMPA, Florida—Statement from Obesity Action Coalition (OAC) President and CEO Joseph Nadglowski:
“Today, there are more than 93 million Americans affected by obesity and one in three children is affected by childhood obesity. With the growing epidemic, reports of children being removed from their parents related to obesity are rare but becoming more common. The OAC encourages officials and the public to recognize the complexity of obesity before making determinations of parental neglect in such circumstances. The causes of obesity are numerous and much more complicated than child or parental behavior including societal, biological, genetic, and environmental factors. In addition, the treatment of obesity, especially in children, is extremely complicated and made very difficult by the lack of effective treatment options, lack of knowledge by the medical community and lack of insurance reimbursement for such services.
It is imperative that we, as a society, ensure that we are doing everything possible on all fronts in the fight against obesity, such as providing adequate and available healthcare, to make sure that America’s children are given the best quality of life possible before we begin deeming the disease of childhood obesity as parental abuse. The OAC is a National nonprofit charity dedicated to helping individuals affected by obesity. The OAC was formed to bring together individuals struggling with weight issues and provide educational resources and advocacy tools.”
For the full press release and for more information, please contact James Zervios, OAC Director of Communications, at (800) 717-3117 or email@example.com.
American Society of Metabolic and Bariatric Surgery and The American Society for Gastrointestinal Endoscopy Issue White Paper on Endoscopic Bariatric Therapies—Societies Explore Role of Endoscopy in Treating Obesity
GAINESVILLE, Florida— The American Society for Gastrointestinal Endoscopy (ASGE) and the American Society for Metabolic and Bariatric Surgery (ASMBS) have issued a new white paper on the potential role of endoscopic bariatric therapies (EBTs) in treating obesity and obesity-related diseases like type 2 diabetes.
The white paper entitled, “A Pathway to Endoscopic Bariatric Therapies,” appears online in both Gastrointestinal Endoscopy (Gastrointest Endosc), the peer-reviewed scientific journal of the ASGE and Surgery for Obesity and Related Diseases (Surg Obes Relat Dis), the peer-reviewed scientific journal of the ASMBS.
According to the white paper, several EBTs are currently in different stages of development and include a wide variety of methods to induce weight loss and reduce obesity-related diseases and conditions.
EBTs are performed entirely through the gastrointestinal tract using thin flexible endoscopes and may offer patients an outpatient alternative to bariatric procedures including laparoscopic gastric bypass, adjustable gastric banding and sleeve gastrectomy.
“Endoscopic therapy has the potential to be applied across the continuum of obesity and metabolic disease,” said Bipan Chand, MD, chairman, ASMBS Emerging Technology and Procedure Committee, and co-chair of the ASGE/ASMBS Task Force. “However, it is generally expected that endoscopic modalities achieve weight loss superior to that produced by medical and intensive lifestyle interventions, have a favorable risk/benefit profile and have scientific evidence to support its use.”
The white paper addresses EBT treatment classification, potential indications, and efficacy including, primary efficacy endpoints, such as weight loss, definitions for weight loss, comparison of weight loss between therapies, threshold for weight loss, and study design; and secondary efficacy endpoints, such as reduction in obesity-related comorbidities, changes in quality of life, safety, durability and repeatability, adoption of EBTs in the context of global patient care, endoscopy unit considerations, training and credentialing, cost effectiveness, and government and industry relations.
To read the full white paper, see the November print issues of Gastrointest Endosc or Surg Obes Relat Dis. Visit www.giejournal.org or http://asmbs.org/soard/ for the online issues.
Category: News and Trends